| Mrs Veronica Kem Smalheiser, NP-C, ANP-BC, CCRN | |
|
300 Midtown Dr, Beaufort, SC 29906-5200 | |
| (843) 770-0404 | |
| (843) 770-0006 |
| Full Name | Mrs Veronica Kem Smalheiser |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 300 Midtown Dr, Beaufort, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235551516 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaufort County Memorial Hospital | Beaufort, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beaufort County Memorial Hospital | 7810809365 | 103 |
News Archive
Cardiovascular Systems, Inc., announced today that its CALCIUM 360° Study, the first-of-its kind prospective, randomized feasibility study, demonstrated the safety and effectiveness of plaque modification with the Diamondback 360 PAD System versus the standard of care treatment (balloon angioplasty) in below-the-knee arteries.
Hypertension or high blood pressure is a major killer worldwide, accounting for much death and disease burden due to cardiovascular disease. Multiple factors influence the risk for this condition, some acting in adulthood but some operating from birth or even earlier.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Edwards Lifesciences Corporation,the global leader in the science of heart valves and hemodynamic monitoring, today announced the Court of Appeals for the Federal Circuit affirmed a previous court decision in favor of Cook Inc. and W. L. Gore & Associates, finding the companies did not infringe Edwards' patents for modular or multi-part endovascular grafts for treatment of abdominal aortic aneurysms (AAA).
Catamaran Corp., a leading provider of pharmacy benefit management services and technology today announced that its specialty brand, BriovaRx, has been awarded Specialty Pharmacy Accreditation from URAC, a Washington, D.C.-based accrediting organization that establishes quality standards for the healthcare industry.
› Verified 8 days ago
| Entity Name | Beaufort County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457922007 PECOS PAC ID: 7810809365 Enrollment ID: O20050208000354 |
News Archive
Cardiovascular Systems, Inc., announced today that its CALCIUM 360° Study, the first-of-its kind prospective, randomized feasibility study, demonstrated the safety and effectiveness of plaque modification with the Diamondback 360 PAD System versus the standard of care treatment (balloon angioplasty) in below-the-knee arteries.
Hypertension or high blood pressure is a major killer worldwide, accounting for much death and disease burden due to cardiovascular disease. Multiple factors influence the risk for this condition, some acting in adulthood but some operating from birth or even earlier.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Edwards Lifesciences Corporation,the global leader in the science of heart valves and hemodynamic monitoring, today announced the Court of Appeals for the Federal Circuit affirmed a previous court decision in favor of Cook Inc. and W. L. Gore & Associates, finding the companies did not infringe Edwards' patents for modular or multi-part endovascular grafts for treatment of abdominal aortic aneurysms (AAA).
Catamaran Corp., a leading provider of pharmacy benefit management services and technology today announced that its specialty brand, BriovaRx, has been awarded Specialty Pharmacy Accreditation from URAC, a Washington, D.C.-based accrediting organization that establishes quality standards for the healthcare industry.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Veronica Kem Smalheiser, NP-C, ANP-BC, CCRN 300 Midtown Dr, Beaufort, SC 29906-5200 Ph: (843) 770-0404 | Mrs Veronica Kem Smalheiser, NP-C, ANP-BC, CCRN 300 Midtown Dr, Beaufort, SC 29906-5200 Ph: (843) 770-0404 |
News Archive
Cardiovascular Systems, Inc., announced today that its CALCIUM 360° Study, the first-of-its kind prospective, randomized feasibility study, demonstrated the safety and effectiveness of plaque modification with the Diamondback 360 PAD System versus the standard of care treatment (balloon angioplasty) in below-the-knee arteries.
Hypertension or high blood pressure is a major killer worldwide, accounting for much death and disease burden due to cardiovascular disease. Multiple factors influence the risk for this condition, some acting in adulthood but some operating from birth or even earlier.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Edwards Lifesciences Corporation,the global leader in the science of heart valves and hemodynamic monitoring, today announced the Court of Appeals for the Federal Circuit affirmed a previous court decision in favor of Cook Inc. and W. L. Gore & Associates, finding the companies did not infringe Edwards' patents for modular or multi-part endovascular grafts for treatment of abdominal aortic aneurysms (AAA).
Catamaran Corp., a leading provider of pharmacy benefit management services and technology today announced that its specialty brand, BriovaRx, has been awarded Specialty Pharmacy Accreditation from URAC, a Washington, D.C.-based accrediting organization that establishes quality standards for the healthcare industry.
› Verified 8 days ago
Marjorie Sapp, APRN, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 694 Paige Dr, Beaufort, SC 29906 Phone: 843-524-4504 | |
Mathew Robert Loe, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Pinckney Blvd, Beaufort, SC 29902 Phone: 843-228-5505 | |
Taylor D Robinson, AGACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 955 Ribaut Rd, Beaufort, SC 29902 Phone: 843-522-5200 | |
Angela Mae Riddle, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 335 Pleasant Point Dr, Beaufort, SC 29907 Phone: 803-699-9073 Fax: 866-527-0937 | |
Alice Armstrong Zengel, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Pinckney Blvd, Naval Hospital Beaufort, Attn:prof Affairs Coordinator, Beaufort, SC 29902 Phone: 843-228-5577 Fax: 843-228-5196 | |
Anna Christine Bennett, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 22 Robert Smalls Pkwy, Beaufort, SC 29906 Phone: 843-510-6550 Fax: 843-510-6555 | |
Jessica Moore Lowther, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 300 Midtown Dr, Beaufort, SC 29906 Phone: 843-379-7746 Fax: 843-522-1275 |